HCV Management in Primary Care: Closing Treatment Gaps in Rural and Underserved Communities
February 28, 2022
February 28, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Postgraduate Institute for Medicine and RME Collaborative.
This activity is supported by an independent educational grant from AbbVie, Inc.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Physicians — maximum of 1.0 ABIM MOC Point
- Nurses — 1.0 Contact Hour (0.5 contact hour of pharmacotherapy credit)
All other healthcare professionals completing this course will be issued a statement of participation.
This activity is designed specifically for primary care clinicians, registered nurses, and advanced practice registered nurses who care for patients from rural and underserved areas.
The introduction of direct-acting oral antiviral agents (DAAs) has transformed the treatment of hepatitis C virus (HCV), leading to high cure rates and short treatment durations. Despite these advances, the use of new DAAs in rural and underserved communities is low owing to limited access to specialty care, distance, and travel time. Expanding primary care capacity to treat HCV infection is therefore critical to improving access and reducing barriers to treatment. This case-based CME/CE activity will review current testing recommendations, therapy selection, and follow-up care after the completion of treatment for HCV. Strategies to improve multidisciplinary care and overcome barriers in rural and underserved areas will also be explored.
This enduring activity is a recorded session from the 3rd Annual Rural Health Clinical Congress that took place on November 20, 2021.
Upon completion of this activity, participants should be better able to:
- Differentiate between available treatment regimens for HCV based on their clinical safety and efficacy
- Apply current treatment recommendations and the latest clinical evidence to appropriately treat patients with HCV
- Implement strategies to overcome barriers and improve multidisciplinary HCV care in rural and underserved communities
Nancy S. Reau, MD, FAASLD, AGAF
Richard B. Capps Chair of Hepatology
Professor, Department of Internal Medicine
Division of Digestive Diseases and Nutrition
Rush Medical College
Section Chief of Hepatology
Associate Director of Organ Transplantation
Rush University Medical Center
Barbara P. Yawn, MD, MSc, FAAFP (Moderator)
Professor of Family and Community Health
University of Minnesota
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RME Collaborative. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. For physicians claiming ABIM MOC credit, your information will be shared through the ACCME’s Program and Activity Reporting System (PARS). Please allow approximately 30 days for your MOC points to appear on your ABIM records.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.5 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine and RME Collaborative adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Postgraduate Institute for Medicine requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies (commercial interests). All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to Postgraduate Institute for Medicine policy. Postgraduate Institute for Medicine is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Nancy S. Reau, MD, FAASLD, AGAF, has disclosed the following relationships: consultant for AbbVie, Inc., Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., and Merck & Co., Inc.; grant/research support from GENFIT, Intercept Pharmaceuticals, Inc., and Shire Pharmaceuticals.
Barbara P. Yawn, MD, MSc, FAAFP, has no relevant financial relationships to disclose.
Planners, Managers, and Reviewer
The Postgraduate Institute for Medicine and RME Collaborative planners, managers, and reviewer have nothing to disclose.
Instructions for Participation and Credit
This activity is offered at no cost to participants. To receive CME/CE credit, participants must:
- Read the CME/CE information, including learning objectives and disclosure statements.
- Complete the pre-test.
- View the online activity.
- Complete the post-test and evaluation form.
For Physicians Claiming ABIM MOC Credit
To obtain MOC credit, you must provide your ABIM number and DOB (MM/DD) in the activity evaluation form.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
©RME Collaborative, a division of Talem Health, LLC 2022. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.
There is no fee for this educational activity.
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or email@example.com.
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine at firstname.lastname@example.org.